Presenting updated data at a significant conference can positively influence investor sentiment by showcasing progress and potential in Gossamer Bio's pipeline. This could lead to increased investor interest and potentially a positive short-term impact on the stock price, especially if the data presented is favorable and highlights the drug's potential market impact.